Sunshine Biopharma SBFM Stock
Sunshine Biopharma Price Chart
Sunshine Biopharma SBFM Financial and Trading Overview
| Sunshine Biopharma stock price | 0.86 USD |
| Previous Close | 0.28 USD |
| Open | 0.28 USD |
| Bid | 0.25 USD x 800 |
| Ask | 0.27 USD x 1100 |
| Day's Range | 0.26 - 0.28 USD |
| 52 Week Range | 0.21 - 1.4 USD |
| Volume | 67.81K USD |
| Avg. Volume | 142.33K USD |
| Market Cap | 6.68M USD |
| Beta (5Y Monthly) | -1.008 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.19 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3 USD |
SBFM Valuation Measures
| Enterprise Value | -11495258 USD |
| Trailing P/E | N/A |
| Forward P/E | 2.8888886 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.3280374 |
| Price/Book (mrq) | 0.30409354 |
| Enterprise Value/Revenue | -0.565 |
| Enterprise Value/EBITDA | 1.351 |
Trading Information
Sunshine Biopharma Stock Price History
| Beta (5Y Monthly) | -1.008 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 1.4 USD |
| 52 Week Low | 0.21 USD |
| 50-Day Moving Average | 0.29 USD |
| 200-Day Moving Average | 0.5 USD |
SBFM Share Statistics
| Avg. Volume (3 month) | 142.33K USD |
| Avg. Daily Volume (10-Days) | 103.31K USD |
| Shares Outstanding | 25.68M |
| Float | 21.56M |
| Short Ratio | 0.29 |
| % Held by Insiders | 16.02% |
| % Held by Institutions | 5.09% |
| Shares Short | 74.15K |
| Short % of Float | 0.33% |
| Short % of Shares Outstanding | 0.28% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:200 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | September 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -131.52% |
| Operating Margin (ttm) | -13.084% |
| Gross Margin | 35.68% |
| EBITDA Margin | -41.80% |
Management Effectiveness
| Return on Assets (ttm) | -15.75% |
| Return on Equity (ttm) | -85.86% |
Income Statement
| Revenue (ttm) | 20.35M USD |
| Revenue Per Share (ttm) | 0.85 USD |
| Quarterly Revenue Growth (yoy) | 4385.90% |
| Gross Profit (ttm) | 1.7M USD |
| EBITDA | -8509198 USD |
| Net Income Avi to Common (ttm) | -26768336 USD |
| Diluted EPS (ttm) | -1.63 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.85M USD |
| Total Cash Per Share (mrq) | 0.73 USD |
| Total Debt (mrq) | 673.53K USD |
| Total Debt/Equity (mrq) | 3.07 USD |
| Current Ratio (mrq) | 4.999 |
| Book Value Per Share (mrq) | 0.855 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8332047 USD |
| Levered Free Cash Flow (ttm) | -7945723 USD |
Profile of Sunshine Biopharma
| Country | United States |
| State | NY |
| City | New York |
| Address | 1177 Avenue of the Americas |
| ZIP | 10036 |
| Phone | 332-216-1147 |
| Website | https://sunshinebiopharma.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 46 |
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; SBFM-PL4, an anti-coronavirus treatment compound; and K1.1 mRNA molecules used as anti-cancer agents. It also offers Essential 9, an amino acids capsules; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. Sunshine Biopharma, Inc. is based in New York, New York.
Q&A For Sunshine Biopharma Stock
What is a current SBFM stock price?
Sunshine Biopharma SBFM stock price today per share is 0.86 USD.
How to purchase Sunshine Biopharma stock?
You can buy SBFM shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sunshine Biopharma?
The stock symbol or ticker of Sunshine Biopharma is SBFM.
Which industry does the Sunshine Biopharma company belong to?
The Sunshine Biopharma industry is Drug Manufacturers-Specialty & Generic.
How many shares does Sunshine Biopharma have in circulation?
The max supply of Sunshine Biopharma shares is 9.26M.
What is Sunshine Biopharma Price to Earnings Ratio (PE Ratio)?
Sunshine Biopharma PE Ratio is now.
What was Sunshine Biopharma earnings per share over the trailing 12 months (TTM)?
Sunshine Biopharma EPS is -0.19 USD over the trailing 12 months.
Which sector does the Sunshine Biopharma company belong to?
The Sunshine Biopharma sector is Healthcare.
Sunshine Biopharma SBFM included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}